Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
Condition:   MGMT-Unmethylated Glioblastoma Intervention:   Drug: Etoposide Plus Cisplatin Sponsor:   Zhongnan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2023 Category: Research Source Type: clinical trials

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Conditions:   Advanced Malignant Solid Neoplasm;   Hematopoietic and Lymphoid System Neoplasm;   Metastatic Malignant Solid Neoplasm Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Drug: Temozolomide;   Drug: Tuvusertib Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2023 Category: Research Source Type: clinical trials